Details

Autor(en) / Beteiligte

• Downie, Mallory L.
• Gupta, Sanjana
• Chan, Melanie M. Y.
• Sadeghi-Alavijeh, Omid
• Cao, Jingjing
• Parekh, Rulan S.
• Diz, Carmen Bugarin
• Bierzynska, Agnieszka
• Levine, Adam P.
• Pepper, Ruth J.
• Stanescu, Horia
• Saleem, Moin A.
• Kleta, Robert
• Bockenhauer, Detlef
• Koziell, Ania B.
• Gale, Daniel P.

Titel

Shared genetic risk across different presentations of gene test–negative idiopathic nephrotic syndrome

Ist Teil von

• Pediatric nephrology (Berlin, West), 2023-06, Vol.38 (6), p.1793-1800

Ort / Verlag

Berlin/Heidelberg: Springer Berlin Heidelberg

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• Background Idiop athic nephrotic syndrome (INS) is classified in children according to response to initial corticosteroid therapy into steroid-sensitive (SSNS) and steroid-resistant nephrotic syndrome (SRNS), and in adults according to histology into minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS). However, there is well-recognised phenotypic overlap between these entities. Genome-wide association studies (GWAS) have shown a strong association between SSNS and variation at HLA, suggesting an underlying immunological basis. We sought to determine whether a risk score generated from genetic variants associated with SSNS could be used to gain insight into the pathophysiology of INS presenting in other ways. Methods We developed an SSNS genetic risk score (SSNS-GRS) from the five variants independently associated with childhood SSNS in a previous European GWAS. We quantified SSNS-GRS in independent cohorts of European individuals with childhood SSNS, non-monogenic SRNS, MCD, and FSGS, and contrasted them with SSNS-GRS quantified in individuals with monogenic SRNS, membranous nephropathy (a different immune-mediated disease-causing nephrotic syndrome), and healthy controls. Results The SSNS-GRS was significantly elevated in cohorts with SSNS, non-monogenic SRNS, MCD, and FSGS compared to healthy participants and those with membranous nephropathy. The SSNS-GRS in all cohorts with non-monogenic INS were also significantly elevated compared to those with monogenic SRNS. Conclusions The shared genetic risk factors among patients with different presentations of INS strongly suggests a shared autoimmune pathogenesis when monogenic causes are excluded. Use of the SSNS-GRS, in addition to testing for monogenic causes, may help to classify patients presenting with INS. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information